[1]
O. Karpenko, “EFFECTS OF ANTIPLATELET TREATMENT ON THROMBOCYTIC AGGREGATING ABILITY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND IN COMBINATION WITH TYPE 2 DIABETES”, USMYJ, vol. 109, no. 1, pp. 11-17, Mar. 2019.